Workflow
IQOS
icon
Search documents
菲莫国际:提出三年规划,聚焦新烟成长
Xinda Securities· 2026-02-08 14:58
菲莫国际:提出三年规划,聚焦新烟成长 [Table_Industry] 轻工制造 [Table_ReportDate] 2026 年 02 月 08 日 证券研究报告 行业研究 [Table_ReportType] 行业事项点评 [Table_StockAndRank] 轻工制造 投资评级 看好 上次评级 看好 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号:S1500524120004 邮箱:jiangwenqiang@cindasc.com 李晨 新消费行业分析师 执业编号:S1500525060001 邮箱:lichen1@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编:100031 [Table_Title] 菲莫国际:提出三年规划,聚焦新烟成长 [Table_ReportDate] 2026 年 02 月 08 日 HNB 全球份额维持高位,日本竞争加剧。公司全年 HNB 销量达 1551 亿 支(同比+11.0%),全球市占率约 76%(倒算全球行业规模 25 年超 200 ...
耐用消费产业行业研究:国际烟草巨头财报频出,泡泡年会更新,苹果官宣AI硬件布局
SINOLINK SECURITIES· 2026-02-08 06:35
耐用消费产业行业研究 2026 年 02 月 08 日 买入(维持评级) 行业周报 证券研究报告 国金证券研究所 分析师:赵中平(执业 S1130524050003 ) zhaozhongping @gjzq.com.cn 分析师:唐执敬(执业 S1130525020002 ) tangzhijing@gjzq.com.cn 联系人:谢俪丹 xielidan@gjzq.com.cn 国际烟草巨头财报频出,泡泡年会更新,苹果官宣 AI 硬件布局 投资逻辑 潮玩:布鲁可登录日本市场、海外版图持续扩张,与 Takara Tomy 合作深入有望进一步推动其 IP 拓展进程。布鲁可 变形金刚星辰版前三弹将率先登岛,此次由日本《变形金刚》IP 官方持有方 Takara Tomy(多美)引入。2 月 5 日泡 泡玛特与中科宇航联名设计的太空主题 SPACE MOLLY 公仔完成太空首秀;2 月 6 日公司举办年会,会上宣布 2025 全 年全品类销售量超 4 亿,Labubu 单品销售量超 1 亿,全球注册会员超 1 亿人,门店数量超 700 家。 新型烟草:菲莫国际业绩会彰显 HNB 赛道长期增长动力,未来有望二次加速, ...
Philip Morris International Q4 Earnings Call Highlights
Yahoo Finance· 2026-02-07 04:07
CFO Emmanuel Babeau said organic net revenue increased 6.5% in 2025, or 7.9% excluding what he described as a “technical Indonesia impact.” Organic operating income rose 10.6% with 140 basis points of organic margin expansion. In dollar terms, adjusted operating income grew 11.8% to $16.4 billion, and adjusted diluted EPS rose 14.2% at constant currency and 15% in dollar terms to $7.54. Babeau noted EPS landed at the high end of the company’s prior guidance range despite a lower-than-expected currency tailw ...
Philip Morris Shares Edge Higher After Q4 Results Meet Expectations and Smoke-Free Growth Continues
Financial Modeling Prep· 2026-02-06 21:01
Core Insights - Philip Morris International Inc. reported fourth-quarter results that met analyst expectations, with adjusted earnings per share of $1.70 and revenue of $10.4 billion, slightly above the expected $10.39 billion [1] Group 1: Financial Performance - The company achieved adjusted diluted EPS of $7.54 for the full year 2025, reflecting a year-over-year growth of 14.8%, or 14.2% on a currency-neutral basis [2] - Revenue from smoke-free products constituted 41.5% of total net revenues and nearly 43% of total gross profit, marking increases of 2.8 and 3.2 percentage points compared to full-year 2024 [3] Group 2: Business Growth and Strategy - Smoke-free shipment volumes increased by 8.5% in the quarter, while traditional cigarette volumes saw a decline of 2.2% [2] - Philip Morris guided for fiscal 2026 adjusted EPS in the range of $8.38 to $8.53, surpassing the analyst consensus of $8.33 [4] - The company set new growth targets for 2026–2028, aiming for organic net revenue growth of 6% to 8%, organic operating income growth of 8% to 10%, and adjusted diluted EPS growth of 9% to 11%, excluding currency effects [4]
The Rotation into Consumer Staples: Defensive Strength in an Uncertain 2026
ZACKS· 2026-02-06 17:55
The beginning of this year has served as a stark reminder of how quickly investor sentiment can shift. In early 2026, we've witnessed a notable rotation into consumer staples stocks, a sector long valued for its defensive qualities. While technology shares have faced pressure amid high valuations and questions around AI momentum sustainability, staples have emerged as a relative haven.The Consumer Staples Select Sector SPDR Fund (XLP) , a benchmark ETF, has risen approximately 13% year-to-date through early ...
Philip Morris (PM) Q4 2025 Earnings Transcript
Yahoo Finance· 2026-02-06 15:42
We accomplished this through strong pricing, portfolio resilience, and disciplined execution, with Marlborough reaching a historic high share. Managing this business responsibly enables us to invest boldly in better alternatives and sustain our smoke-free momentum. Together, these factors enabled us to deliver 15% adjusted diluted EPS growth in dollar terms, the strongest growth since 2011, excluding the pandemic recovery year of 2021. This reflects currency-neutral growth of 14% well above our expectations ...
PMI(PM) - 2025 Q4 - Earnings Call Transcript
2026-02-06 15:02
Philip Morris International (NYSE:PM) Q4 2025 Earnings call February 06, 2026 09:00 AM ET Company ParticipantsEmmanuel Babeau - CFOEric Serotta - Executive Director for US Beverages, Tobacco, and Household ProductsJacek Olczak - Group CEOJames Bushnell - VP of Investor Relations and Financial CommunicationConference Call ParticipantsBonnie Herzog - Managing Director and Veteran AnalystDamian McNeela - Director and Senior Analyst of Consumer StaplesFaham Baig - Global Tobacco Analyst and Executive DirectorGe ...
PMI(PM) - 2025 Q4 - Earnings Call Transcript
2026-02-06 15:02
Philip Morris International (NYSE:PM) Q4 2025 Earnings call February 06, 2026 09:00 AM ET Company ParticipantsEmmanuel Babeau - CFOJacek Olczak - Group CEOJames Bushnell - VP of Investor Relations and Financial CommunicationConference Call ParticipantsGerald Pascarelli - Senior Analyst of Beverages, Tobacco, and CannabisMatt Smith - Senior Analyst of Consumer StaplesOperatorday and thank you for standing by. Welcome to the Philip Morris International, Inc., 2025 fourth quarter results conference call. At th ...
PMI(PM) - 2025 Q4 - Earnings Call Transcript
2026-02-06 15:00
Financial Data and Key Metrics Changes - In 2025, total net revenues exceeded $40 billion, with 41.5% or nearly $17 billion generated from smoke-free products [8][11] - Adjusted diluted EPS grew by 15% in dollar terms, marking the strongest growth since 2011, excluding the pandemic recovery year of 2021 [5][11] - Organic top-line growth was +6.5%, with adjusted operating income growth at +10.6%, reflecting +140 basis points of organic margin expansion [11][12] Business Line Data and Key Metrics Changes - Smoke-free product volumes grew by 12.8%, with organic smoke-free gross profit growth of 18.7% [3][12] - IQOS shipments grew by approximately 11%, with a notable acceleration in the fourth quarter [3][15] - ZYN shipments in the U.S. increased by 37%, contributing significantly to smoke-free product growth [5][14] Market Data and Key Metrics Changes - The international business generated the majority of total PMI organic net revenue growth, with smoke-free products leading the way [5][19] - In Japan, the heat-not-burn category surpassed 50% of total industry volumes, driven by IQOS [25][26] - The U.S. market for nicotine pouches saw ZYN capturing around 50% of category growth, with a volume share of 61.5% [30][22] Company Strategy and Development Direction - The company continues to focus on a multi-category strategy, expanding its smoke-free product offerings and geographic reach [4][9] - There is a strong emphasis on innovation and digitalization to support long-term growth [9][43] - The company targets a leverage ratio of close to 2x by the end of 2026, indicating a focus on financial flexibility and shareholder returns [7][44] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving strong growth despite transitory headwinds, with a forecast of 5%-7% organic net revenue growth for 2026 [36][37] - The company anticipates continued strong cash generation, with operating cash flow projected at around $13.5 billion [38][43] - Management highlighted the importance of navigating regulatory environments and enhancing brand equity for future growth [32][33] Other Important Information - The company achieved a historic high share for Marlboro, reaching 11% of the international category, excluding China [34][5] - The number of legal-age consumers of smoke-free products reached an estimated 43.5 million, reflecting broad-based growth across categories [20][19] - The company is committed to delivering superior shareholder value, with a target dividend payout ratio of around 75% of adjusted diluted EPS [44][45] Q&A Session Summary Question: Can you expand on the reacceleration in smoke-free volume growth compared to the 2026 growth guidance? - Management indicated that the acceleration is expected due to tax changes in Japan and competitive dynamics in the U.S. market [49][50] Question: How are you thinking in terms of IQOS, HTU shipments, and IMS for 2026? - Management noted that while Japan faces challenges, other markets like Italy and Germany are showing strong growth, contributing positively to IQOS's outlook [58][62] Question: What are the key growth drivers for the upcoming year? - Management emphasized the importance of ZYN and IQOS, along with ongoing investments in marketing and innovation, as key drivers for growth [72][75]
PMI(PM) - 2025 Q4 - Earnings Call Presentation
2026-02-06 14:00
2025 Fourth-Quarter and Full-Year Results February 6, 2026 Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibit 99.2 to the company's Form 8-K dated February 6, 2026 and on our Investor Relations website with additional non- GAAP reconciliations available at the end of this presentation 2 Forward-Looking and Cautionary Statements ...